IRM cardiaque mettent en évidence : ? Une corrélation forte (r=0,77) entre le débit systémique à l'IRM et la ,
Updated Clinical Classification of Pulmonary Hypertension, Journal of the American College of Cardiology, vol.54, issue.1, pp.43-54, 2009. ,
DOI : 10.1016/j.jacc.2009.04.012
Clinical classification of pulmonary hypertension, Journal of the American College of Cardiology, vol.43, issue.12, pp.5-12, 2004. ,
DOI : 10.1016/j.jacc.2004.02.037
Severe Pulmonary Hypertension in Histiocytosis X, American Journal of Respiratory and Critical Care Medicine, vol.66, issue.1, pp.216-239, 2000. ,
DOI : 10.1056/NEJM199701093360207
Guidelines for the diagnosis and treatment of pulmonary hypertension, Revista Portuguesa de Cardiologia (English Edition), vol.31, issue.1, pp.219-1263, 2009. ,
DOI : 10.1016/j.repce.2011.10.006
Increased plasma serotonin in primary pulmonary hypertension, The American Journal of Medicine, vol.99, issue.3, pp.249-54, 1995. ,
DOI : 10.1016/S0002-9343(99)80156-9
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension, Journal of Clinical Investigation, vol.108, issue.8, pp.1141-50, 2001. ,
DOI : 10.1172/JCI200112805
Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease, Circulation, vol.108, issue.15, pp.1839-1883, 2003. ,
DOI : 10.1161/01.CIR.0000091409.53101.E8
Heterozygous germline mutations in a TGF-beta receptor, BMPR2, are the cause of familial primary pulmonary hypertension, Nat Genet, vol.26, pp.81-85, 2000. ,
Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor???II Gene, The American Journal of Human Genetics, vol.67, issue.3, pp.737-781, 2000. ,
DOI : 10.1086/303059
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives, European Respiratory Journal, vol.20, issue.3, pp.518-541, 2002. ,
DOI : 10.1183/09031936.02.01762002
Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-??1 and Bone Morphogenetic Proteins, Circulation, vol.104, issue.7, pp.790-795, 2001. ,
DOI : 10.1161/hc3201.094152
Inflammation in pulmonary arterial hypertension, European Respiratory Journal, vol.22, issue.2, pp.358-63, 2003. ,
DOI : 10.1183/09031936.03.00038903
Primary Pulmonary Hypertension, New England Journal of Medicine, vol.336, issue.2, pp.111-118, 1997. ,
DOI : 10.1056/NEJM199701093360207
Primary pulmonary hypertension, The Lancet, vol.361, issue.9368, pp.1533-1577, 2003. ,
DOI : 10.1016/S0140-6736(03)13167-4
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension, European Respiratory Journal, vol.12, issue.2, pp.265-70, 1998. ,
DOI : 10.1183/09031936.98.12020265
Antinuclear antibodies in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.8, issue.6, pp.1307-1318, 1986. ,
DOI : 10.1016/S0735-1097(86)80301-1
Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.132, issue.2, pp.487-92, 2000. ,
DOI : 10.1161/01.CIR.89.4.1733
Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension, European Respiratory Journal, vol.17, issue.4, pp.647-52, 2001. ,
DOI : 10.1183/09031936.01.17406470
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension, Circulation, vol.102, issue.8, pp.865-70, 2000. ,
DOI : 10.1161/01.CIR.102.8.865
Big Endothelin-1 and Endothelin-1 Plasma Levels Are Correlated With the Severity of Primary Pulmonary Hypertension, Chest, vol.120, issue.5, pp.1562-1571, 2001. ,
DOI : 10.1378/chest.120.5.1562
Serum Uric Acid Levels Correlate with the Severity and the Mortality of Primary Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.39, issue.2, pp.487-92, 1999. ,
DOI : 10.1056/NEJM197906283002604
Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension, Circulation, vol.108, issue.7, pp.844-852, 2003. ,
DOI : 10.1161/01.CIR.0000084544.54513.E2
Primary pulmonary hypertension: natural history and the importance of thrombosis, Circulation, vol.70, issue.4, pp.580-587, 1984. ,
DOI : 10.1161/01.CIR.70.4.580
Primary Pulmonary Hypertension: A Histopathologic Study of 80 Cases, Mayo Clinic Proceedings, vol.60, issue.1, pp.16-25, 1985. ,
DOI : 10.1016/S0025-6196(12)65277-X
RISK FACTORS FOR PULMONARY ARTERIAL HYPERTENSION, Clinics in Chest Medicine, vol.22, issue.3, pp.459-75, 2001. ,
DOI : 10.1016/S0272-5231(05)70284-7
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension, Circulation, vol.111, issue.23, pp.3105-3111, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.104.488486
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension, New England Journal of Medicine, vol.334, issue.5, pp.296-302, 1996. ,
DOI : 10.1056/NEJM199602013340504
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.40, issue.4, pp.780-788, 2002. ,
DOI : 10.1016/S0735-1097(02)02012-0
Survival in Primary Pulmonary Hypertension, Circulation, vol.106, issue.12, pp.1477-1482, 2002. ,
DOI : 10.1161/01.CIR.0000029100.82385.58
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease, European Respiratory Journal, vol.34, issue.6, pp.1348-1356, 2009. ,
DOI : 10.1183/09031936.00017809
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.1, issue.6, pp.800-804, 2002. ,
DOI : 10.7326/0003-4819-115-5-343
Inhaled Iloprost for Severe Pulmonary Hypertension, New England Journal of Medicine, vol.347, issue.5, pp.322-329, 2002. ,
DOI : 10.1056/NEJMoa020204
URL : http://www.nejm.org/doi/pdf/10.1056/NEJMoa020204
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study, The Lancet, vol.358, issue.9288, pp.1119-1123, 2001. ,
DOI : 10.1016/S0140-6736(01)06250-X
Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study, Circulation, vol.114, issue.1, pp.48-54, 2006. ,
DOI : 10.1161/CIRCULATIONAHA.106.630715
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial, The Lancet, vol.371, issue.9630, pp.2093-2100, 2008. ,
DOI : 10.1016/S0140-6736(08)60919-8
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2, European Respiratory Journal, vol.24, issue.3, pp.353-359, 2004. ,
DOI : 10.1183/09031936.04.00028404
Bosentan Therapy for Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.346, issue.12, pp.896-903, 2002. ,
DOI : 10.1056/NEJMoa012212
Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the, ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), pp.1219-1263, 2009. ,
Results of European post-marketing surveillance of bosentan in pulmonary hypertension, European Respiratory Journal, vol.30, issue.2, pp.338-344, 2007. ,
DOI : 10.1183/09031936.00138706
Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan, Journal of the American College of Cardiology, vol.47, issue.10, pp.2049-2056, 2006. ,
DOI : 10.1016/j.jacc.2006.01.057
Sitaxsentan Therapy for Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.169, issue.4, pp.441-447, 2004. ,
DOI : 10.1016/0021-9681(85)90035-9
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2, Circulation, vol.117, issue.23, pp.3010-3019, 2008. ,
DOI : 10.1161/CIRCULATIONAHA.107.742510
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.353, issue.20, pp.2148-2157, 2005. ,
DOI : 10.1056/NEJMoa050010
Tadalafil Therapy for Pulmonary Arterial Hypertension, Circulation, vol.119, issue.22, pp.2894-2903, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.108.839274
Treatment of Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.14, pp.1425-1436, 2004. ,
DOI : 10.1056/NEJMra040291
URL : https://hal.archives-ouvertes.fr/hal-01455600
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.11, pp.1257-1263, 2006. ,
DOI : 10.1183/09031936.04.00051104
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension, Annals of Internal Medicine, vol.149, issue.8, pp.521-530, 2008. ,
DOI : 10.7326/0003-4819-149-8-200810210-00004
Idy-Peretti I. Imagerie par résonance magnétique, 2004. ,
Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension, European Respiratory Journal, vol.33, issue.6, pp.1454-1466, 2009. ,
DOI : 10.1183/09031936.00139907
Clinical Indications for Cardiovascular Magnetic Resonance (CMR): Consensus Panel Report #, Journal of Cardiovascular Magnetic Resonance, vol.6, issue.4, pp.727-65, 2004. ,
DOI : 10.1081/JCMR-200038581
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy, The American Journal of Cardiology, vol.90, issue.1, pp.29-34, 2002. ,
DOI : 10.1016/S0002-9149(02)02381-0
Normal left ventricular dimensions and function: interstudy reproducibility of measurements with cine MR imaging., Radiology, vol.174, issue.3, pp.763-768, 1990. ,
DOI : 10.1148/radiology.174.3.2305059
Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance, American Heart Journal, vol.147, issue.2, pp.218-223, 2004. ,
DOI : 10.1016/j.ahj.2003.10.005
Quantitative analysis of PC MRI velocity maps: pulsatile flow in cylindrical vessels, Magnetic Resonance Imaging, vol.19, issue.5, pp.685-695, 2001. ,
DOI : 10.1016/S0730-725X(01)00376-9
Recent Advances in Magnetic Resonance Perfusion Imaging of the Lung, Topics in Magnetic Resonance Imaging, vol.14, issue.3, pp.245-251, 2003. ,
DOI : 10.1097/00002142-200306000-00005
Evaluation of Right Ventricular Performance With a Right Ventricular Ejection Fraction Thermodilution Catheter and MRI in Patients With Pulmonary Hypertension, Chest, vol.120, issue.2, pp.502-507, 2001. ,
DOI : 10.1378/chest.120.2.502
Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease, American Journal of Respiratory and Critical Care Medicine, vol.167, issue.5, pp.735-740, 2003. ,
DOI : 10.1164/rccm.2107027
Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis, Rheumatology, vol.36, issue.2, pp.239-243, 1997. ,
DOI : 10.1093/rheumatology/36.2.239
Chronic Thromboembolic Pulmonary Hypertension, New England Journal of Medicine, vol.345, issue.20, pp.1465-1472, 2001. ,
DOI : 10.1056/NEJMra010902
Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers, Journal of the American College of Cardiology, vol.48, issue.12, pp.2546-2552, 2006. ,
DOI : 10.1016/j.jacc.2006.07.061
The Effect of Right Ventricular Hypertrophy on Left Ventricular Ejection Fraction in Pulmonary Emphysema, Chest, vol.112, issue.3, pp.640-645, 1997. ,
DOI : 10.1378/chest.112.3.640
Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension, European Heart Journal, vol.28, issue.10, pp.1250-1257, 2007. ,
DOI : 10.1093/eurheartj/ehl477
Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension, Am J Physiol Heart Circ Physiol, vol.290, pp.1528-1533, 2006. ,
Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging, Journal of the American College of Cardiology, vol.21, issue.6, pp.1475-1481, 1993. ,
DOI : 10.1016/0735-1097(93)90327-W
Interventricular Septal Configuration at MR Imaging and Pulmonary Arterial Pressure in Pulmonary Hypertension, Radiology, vol.234, issue.3, pp.710-717, 2005. ,
DOI : 10.1148/radiol.2343040151
Extent of MRI Delayed Enhancement of Myocardial Mass Is Related to Right Ventricular Dysfunction in Pulmonary Artery Hypertension, American Journal of Roentgenology, vol.188, issue.2, pp.349-355, 2007. ,
DOI : 10.2214/AJR.05.1259
Pulmonary artery distensibility and blood flow patterns: A magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension, American Heart Journal, vol.118, issue.5, pp.990-999, 1989. ,
DOI : 10.1016/0002-8703(89)90235-4
Pulmonary hypertension: pulmonary flow quantification and flow profile analysis with velocity-encoded cine MR imaging., Radiology, vol.183, issue.3, pp.751-758, 1992. ,
DOI : 10.1148/radiology.183.3.1584932
Pulmonary Arterial Resistance: Noninvasive Measurement with Indexes of Pulmonary Flow Estimated at Velocity-encoded MR Imaging???Preliminary Experience, Radiology, vol.212, issue.3, pp.896-902, 1999. ,
DOI : 10.1148/radiology.212.3.r99au21896
Pulmonary artery distensibility and blood flow patterns: A magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension, American Heart Journal, vol.118, issue.5, pp.990-999, 1989. ,
DOI : 10.1016/0002-8703(89)90235-4
Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study, European Respiratory Journal, vol.29, issue.3, pp.476-481, 2007. ,
DOI : 10.1183/09031936.00016806
Noninvasively Assessed Pulmonary Artery Stiffness Predicts Mortality in Pulmonary Arterial Hypertension, Chest, vol.132, issue.6, pp.1906-1912, 2007. ,
DOI : 10.1378/chest.07-1246
Magnetic resonance imaging in pulmonary arterial hypertension, The American Journal of Cardiology, vol.56, issue.15, pp.938-942, 1985. ,
DOI : 10.1016/0002-9149(85)90408-4
Evaluation of Cor Pulmonale on a Modified Short-axis Section of the Heart by Magnetic Resonance Imaging, American Review of Respiratory Disease, vol.18, issue.6, pp.1576-1581, 1992. ,
DOI : 10.1161/01.CIR.56.2.278
Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction, European Heart Journal, vol.28, issue.10, pp.49-54, 2009. ,
DOI : 10.1093/eurheartj/ehm074
Clinical classification of pulmonary hypertension, Journal of the American College of Cardiology, vol.43, issue.12, pp.5-12, 2004. ,
DOI : 10.1016/j.jacc.2004.02.037
Interpretation of High Wedge Pressure on Exercise in Patients with Chronic Obstructive Pulmonary Disease, Cardiology, vol.95, issue.3, pp.139-145, 2001. ,
DOI : 10.1159/000047360
Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1030, 2006. ,
DOI : 10.1183/09031936.04.00010904
Quantification of hemodynamics in primary pulmonary hypertension with magnetic resonance imaging., American Journal of Respiratory and Critical Care Medicine, vol.150, issue.4, pp.1075-1080, 1994. ,
DOI : 10.1164/ajrccm.150.4.7921439
Survival in Patients with Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.115, issue.5, pp.343-349, 1991. ,
DOI : 10.7326/0003-4819-115-5-343
The role of 1.5T cardiac MRI in the diagnosis, prognosis and management of pulmonary arterial hypertension, The International Journal of Cardiovascular Imaging, vol.132, issue.6, 2010. ,
DOI : 10.1016/j.jacc.2008.01.024